Anti-CD4 monoclonal antibody 4162W94

Drug Profile

Anti-CD4 monoclonal antibody 4162W94

Alternative Names: 4162W94; Monoclonal antibody 4162W94

Latest Information Update: 05 Dec 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Monoclonal antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 05 Dec 2002 A study has been added to the adverse events and therapeutic trials sections
  • 20 Jul 1999 Discontinued-II for Rheumatoid arthritis in United Kingdom (Unknown route)
  • 01 Mar 1999 Profile reviewed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top